Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03367520 · ClinicalTrials.gov registry record · NA
Helping Veterans With SMI "StayQuit" From Smoking After Inpatient Hospitalization
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT03367520 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 29 participants.
The verdict
NCT03367520, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Given the high prevalence and great cost of smoking for individuals with serious mental illness, an effective smoking cessation intervention for this group of smokers that begins in the hospital and continues following discharge is needed. The investigators will develop and pilot test StayQuit, a multifaceted smoking cessation intervention for smokers with serious mental illness that begins in the hospital and continues for three months after discharge. StayQuit will provide a personalized and tailored experience for smokers with serious mental illness at different levels of motivation to remain abstinent. In the hospital, StayQuit will include a brief motivational intervention that will help smokers relate sustained smoking cessation to their values and preferences, shore up motivation to stay quit, and gain experience using nicotine replacement therapy. This will be followed by cessation-focused discharge planning to engage Veterans in continued smoking cessation services with StayQuit staff. After discharge, StayQuit will offer 13 weeks (spread out over 3 months) of smoking cessation telephone counseling. The investigators will examine the feasibility of StayQuit by collecting both quantitative data on attendance and qualitative data on participants' experiences.
Interventions
- BEHAVIORAL StayQuit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2017-06-07 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03367520
The ClinicalTrials.gov registry entry for NCT03367520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which StayQuit is the first listed.
NCT03367520 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03367520 about?
NCT03367520 is a clinical study titled "Helping Veterans With SMI "StayQuit" From Smoking After Inpatient Hospitalization". Given the high prevalence and great cost of smoking for individuals with serious mental illness, an effective smoking cessation intervention for this group of smokers that begins in the hospital and continues following discharge is needed. The investigators will develop and pilot test StayQuit, a mu...
What is the current status of trial NCT03367520?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2017-06-07. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03367520?
The interventions under investigation include: StayQuit (BEHAVIORAL).
Who is sponsoring clinical trial NCT03367520?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.